- 1. (E)-2-Butenedioic Acid
- (UMLS (NCI) C0060825) =Organic Chemical; Pharmacologic Substance ;
=fumarate;
Inactive Ingredient Preparations =AL OH 400MG/MG OH 400MG/SIMETHICONE 30MG TAB,CHEWABLE;
| - 14. EBSTEIN'S ANOMALY
- [A congenital heart defect characterized by downward or apical displacement of the TRICUSPID VALVE, usually with the septal and posterior leaflets being attached to the wall of the RIGHT VENTRICLE. It is characterized by a huge RIGHT ATRIUM and a small and less effective right ventricle. ( MSH )] (UMLS (ICD9CM) C0013481) =Congenital Abnormality =CONG HEART ANOMALY NOS;
|
- 2. (E)-2-Butenedioic Acid, Dimethyl Ester
- (UMLS (NCI) C0058218) =Organic Chemical; Pharmacologic Substance ;
| - 15. EBV Infection
- [Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY). ( MSH )] (UMLS (NCI) C0149678) =Disease or Syndrome =Herpesviridae disease;
Tumor Virus Infections =Acute B Cell Lymphocytic Leukemia;
glandular fever;
Hairy Leukoplakia of Mouth |
- 3. (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate
- [The mesylate salt form of eprosartan, a non-biphenyl, non-tetrazole, nonpeptide angiotensin II antagonist with antihypertensive activity. Eprosartan mesylate antagonizes angiotensin II type I receptors in tissues such as vascular smooth muscle and the adrenal gland. This prevents angiotensin II-induced vasoconstriction and prevents angiotensin II-mediated stimulation of aldosterone secretion by the adrenal cortex, which decreases the excretion of sodium and water and increases the excretion of potassium. ( NCI )] (UMLS (NCI) C0772203) 2-Thiophenepropanoic Acid, alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)methylene)-,(E)-, Monomethanesulfonate;
Eprosartan Mesylate;
EPROSARTAN MESYLATE PREPARATION =Organic Chemical; Pharmacologic Substance =Eprosartan;
=EPROSARTAN MESYLATE 400 MG;
EPROSARTAN MESYLATE 600 MG | - 16. EBV Related Burkitt's Lymphoma
- (UMLS (NCI) C1333427) EBV-Related Burkitt's Lymphoma;
Epstein-Barr Virus-Related Burkitt Lymphoma;
Epstein-Barr Virus-Related Burkitt's Lymphoma =Neoplastic Process; ;
|
- 4. EB simplex
- [ ] (UMLS (CSP) C0079299) =Congenital Abnormality; Disease or Syndrome
| - 17. EBV Related Carcinoma
- (UMLS (NCI) C1333428) EBV-Related Carcinoma;
Epstein-Barr Virus Related Carcinoma;
Epstein-Barr Virus-Related Carcinoma =Neoplastic Process; ;
|
- 5. EB1089
- (UMLS (NCI) C0287937) =Organic Chemical; Pharmacologic Substance
| - 18. EBV Related Clonal PTLD
- (UMLS (NCI) C1333429) EBV-Related Clonal PTLD;
Epstein-Barr Virus-Related Clonal Post-Transplant Lymphoproliferative Disorder;
=Neoplastic Process; ;
|
- 6. EBAF
- [Endometrial Bleeding Associated Factor, encoded by the human EBAF gene, is a member of the TGF-beta family of proteins. This protein is secreted and plays a role in left-right asymmetry determination of organ systems during development. It is transiently expressed before and during menstrual bleeding and may also play a role in endometrial bleeding. Mutations in this gene have been associated with left-right axis malformations, particularly in the heart and lungs. Some types of infertility have been associated with dysregulated expression of this gene in the endometrium. Alternative processing of this protein can yield three different products. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0916169) Endometrial Bleeding Associated Factor;
Endometrial Bleeding-Associated Factor;
LEFTA;
Left-Right Determination Factor A;
LEFTY 1, Mouse, Homolog of;
LEFTY A;
LEFTY1;
LEFTY2;
LEFTYA;
Lefty-A Protein;
MGC46222;
TGFB4;
TGF-Beta 4;
Transforming Growth Factor Beta 4;
Transforming Growth Factor, Beta-4;
"Transforming Growth Factor, Beta-4 (Endometrial Bleeding-Associated Factor; LEFTY A)" =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 19. EBV Related Hodgkin's Lymphoma
- (UMLS (NCI) C1333430) EBV-Related Hodgkin's Lymphoma;
Epstein-Barr Virus Related Hodgkin's Lymphoma;
Epstein-Barr Virus-Related Hodgkin Lymphoma;
Epstein-Barr Virus-Related Hodgkin's Lymphoma;
=Neoplastic Process; ;
|
- 7. EBCDIC
- [HL7 is indifferent to the use of this Charset. ( HL7V3.0 )] (UMLS (HL7) C1555013) =Intellectual Product =Charset;
| - 20. EBV Related Lymphoma
- (UMLS (NCI) C1333431) EBV-Related Lymphoma;
Epstein-Barr Virus Related Lymphoma;
Epstein-Barr Virus-Related Lymphoma =Neoplastic Process; ;
|
- 8. EBNA3
- [Viral nuclear antigen expressed in latency ( NCI )] (UMLS (NCI) C1333435) Epstein Barr Nuclear Antigen 3 =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 21. EBV Related Malignancy
- (UMLS (NCI) C1333432) EBV-Related Malignancy;
Epstein-Barr Virus Related Malignancy;
Epstein-Barr Virus-Related Malignancy;
Epstein-Barr Virus-Related Malignant Neoplasm;
=Neoplastic Process; ;
|
- 9. Ebola Hemorrhagic Fever
- [A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire. ( MSH )] (UMLS (NCI) C0282687) =Disease or Syndrome =hemorrhagic fever;
Filoviridae Infections | - 22. EBV Related Non-Hodgkin's Lymphoma
- (UMLS (NCI) C1333433) EBV-Related Non-Hodgkin's Lymphoma;
Epstein-Barr Virus Related Non-Hodgkin's Lymphoma;
Epstein-Barr Virus-Related Non-Hodgkin Lymphoma;
Epstein-Barr Virus-Related Non-Hodgkin's Lymphoma;
=Neoplastic Process; ;
|
- 10. Ebola virus
- [genus in family Filoviridae causing outbreaks of a hemorrhagic disease in humans. ( CSP )] (UMLS (CSP) C0013480) =Virus =Mononegavirales;
| - 23. EBV-Related PTLD
- (UMLS (NCI) C1333434) Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder =Neoplastic Process; ;
|
- 11. Ebola-like virus
- [A genus in the family FILOVIRIDAE consisting of several distinct species of Ebolavirus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease (HEMORRHAGIC FEVER, EBOLA) in humans, usually with high mortality. ( MSH )] (UMLS (CSP) C0949892) =Virus ;
| - 24. EBV-specific CTL
- [A white blood cell that is derived from a lymphocyte stem cell matured in the thymus and characterized by a CD8 marker on the surface and an antigen-specific Epstein Barr virus T cell receptor. ( NCI )] (UMLS (NCI) C0393073) =Cell
|
- 12. EBP
- [A protein which binds to an enhancer. Typically, it binds to a cis enhancer element and modifies the transcriptional activity of the associated gene. ( NCI )] (UMLS (CSP) C0597716) =Amino Acid, Peptide, or Protein; Biologically Active Substance =DNA binding protein;
| - 25. EBV-Specific Cytotoxic T-Lymphocytes
- [A preparation of cytotoxic T-lymphocytes (CTL) specifically reactive to Epstein-Barr virus (EBV) latent membrane protein-2A (LMP2A) with potential antineoplastic activity. T-lymphocytes are exposed ex vivo to dendritic cells (DCs) transfected with a replication-deficient adenovirus encoding EBV LMP2A. These LMP2A-specific CTLs are subsequently exposed to EBV infected cells transfected with adenovirus encoding LMP2A, thereby further stimulating CTLs. Administered into patients with EBV-positive tumors, LMP2A-specific CTLs target LMPA-positive cells, resulting in cell lysis and inhibition of cancer cell proliferation. EBV LMP2A is expressed in various EBV-positive malignancies, including nasopharyngeal carcinoma, EBV-positive Hodgkin's and non-Hodgkin's lymphomas. ( NCI )] (UMLS (NCI) C1328049) LMP2A-Specific CTL;
LMP2A-Specific Cytotoxic T-Lymphocytes =Cell; Pharmacologic Substance |
- 13. Ebselen
- (UMLS (NCI) C0058903) =Organic Chemical; Pharmacologic Substance
| |
home
